Molecular glue degraders: Lilly, AbbVie sign billion-dollar deals; BMS leads with three late-stage drugs

Data Compilation
#PharmaFlow

Pipeline Prospector Feb 2025: Bain buys Mitsubishi Tanabe for US$ 3.4 bn; Japan’s Ono gets FDA nod for rare joint tumor drug

Stock Recap
#PipelineProspector

Atazanavir Sulfate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

47 API Suppliers, 25 USDMF, 7 CEP/COS, 16 EU WC, 2 KDMF, 19 NDC API, 21 Listed Suppliers, $ API Reference Price

FINISHED DOSAGE FORMULATIONS

69 FDF Dossiers, 42 FDA Orange Book, 8 Europe, 11 Canada, 2 South Africa, 6 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 300MG BASE;150MG, CAPSULE;ORAL - EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - EQ 200MG BASE, CAPSULE;ORAL - EQ 300MG BASE

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 1 SPI Pharma, 8 DKSH, 4 Faran Shimi Pharmaceutical, 5 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 ACG Worldwide, 1 Actylis, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 8 BASF, 6 DFE Pharma, 1 Finar, 6 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 17 Kerry, 3 Lonza Capsugel, 12 Microlex e.U, 2 Pharmatrans-Sanaq, 4 Pluviaendo, 4 Prachin Chemical, 1 Qualicaps, 14 Roquette, 3 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 11 Sigachi Industries, 1 Valens Pharmachem, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

43 Fillers, Diluents & Binders, 22 Disintegrants & Superdisintegrants, 20 Thickeners and Stabilizers, 16 Lubricants & Glidants, 15 Granulation, 14 Direct Compression, 13 Coating Systems & Additives, 8 Film Formers & Plasticizers, 8 Empty Capsules, 7 Co-Processed Excipients, 7 Taste Masking, 7 Topical, 7 Emulsifying Agents, 4 Parenteral, 4 Solubilizers, 4 Controlled & Modified Release, 3 Chewable & Orodispersible Aids, 3 Surfactant & Foaming Agents, 3 Coloring Agents, 2 Rheology Modifiers, 1 API Stability Enhancers

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 10 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 5 Annual Reports

MARKET PLACE

1 FDF Dossiers

1 FDF Dossiers

PATENTS & EXCLUSIVITIES

2 US Patents, 8 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 USP, 1 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	Registration No.	Compound	Registration Date	Manufacturer	Manufacturer's Country	Manufacturer's Address
28/03/2025	Siegfried AG	Switzerland	Korea BMS Pharmaceutical Co., Ltd.	Su342-15-ND	Atazanavir sulfate	2021-03-16	Siegfried St. Vulbas SAS	France	Parc Industriel de la Plaine de I`Ain 530 Allee de la Luye 01150 SAINT-VULBAS, France
28/03/2025	SK Biotek	U.S.A	Korea BMS Pharmaceutical Co., Ltd.	Su335-4-ND	Atazanavir sulfate	2009-08-21	SK Biotek Ireland Limited	Ireland	Watery Lane, Swords, County Dublin

Atazanavir Sulfate

Atazanavir Sulfate

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

47 API Suppliers

25 USDMF

7 CEP/COS

16 EU WC

2 KDMF

19 NDC API

21 Listed Suppliers

$ API Reference Price

FINISHED DOSAGE FORMULATIONS

69 FDF Dossiers

42 FDA Orange Book

8 Europe

11 Canada

2 South Africa

6 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 300MG BASE;150MG

CAPSULE;ORAL - EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - EQ 200MG BASE

CAPSULE;ORAL - EQ 300MG BASE

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc

1 SPI Pharma

8 DKSH

4 Faran Shimi Pharmaceutical

5 Gangwal Healthcare

3 Nanjing Well Pharmaceutical

1 Pfanstiehl

4 ACG Worldwide

1 Actylis

6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

8 BASF

6 DFE Pharma

1 Finar

6 Gangwal Chemicals

1 Ideal Cures Pvt Ltd

2 Ingredion Pharma Solutions

17 Kerry

3 Lonza Capsugel

12 Microlex e.U

2 Pharmatrans-Sanaq

4 Pluviaendo

4 Prachin Chemical

1 Qualicaps

14 Roquette

3 Seppic

3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

11 Sigachi Industries

1 Valens Pharmachem

4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

43 Fillers, Diluents & Binders

22 Disintegrants & Superdisintegrants

20 Thickeners and Stabilizers

16 Lubricants & Glidants

15 Granulation

14 Direct Compression

13 Coating Systems & Additives

8 Film Formers & Plasticizers

8 Empty Capsules

7 Co-Processed Excipients

7 Taste Masking

7 Topical

7 Emulsifying Agents

4 Parenteral

4 Solubilizers

4 Controlled & Modified Release

3 Chewable & Orodispersible Aids

3 Surfactant & Foaming Agents

3 Coloring Agents

2 Rheology Modifiers

1 API Stability Enhancers

CAPSULE;ORAL - EQ 100MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - EQ 150MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons